| Dr Brian Andrus Pahn, DO | |
|
850 W Baraga Ave, Marquette, MI 49855-4550 | |
| (906) 449-3246 | |
| Not Available |
| Full Name | Dr Brian Andrus Pahn |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 12 Years |
| Location | 850 W Baraga Ave, Marquette, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679836019 | NPI | - | NPPES |
| 1679836019 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 5101026175 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marquette General Hospital | Marquette, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Laboratories Of Marquette Pc | 6800802661 | 5 |
News Archive
PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.
Fear of public reporting of mortality rates may explain why cardiologists in New York are less likely than cardiologists in Michigan to perform angioplasty and other percutaneous coronary interventions on higher risk patients, according to a new study in the June 7, 2005, issue of the Journal of the American College of Cardiology.
Today the United States Centers for Disease Control and Prevention issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis. In these landmark guidelines, CDC advises that Interferon Gamma Release Assay blood tests are now preferred over the 100+-year-old tuberculin skin test for diagnosing TB infection in certain populations, including people who typically do not return for the necessary reading of TST results, and those who have received Bacille Calmette-Guerin as a vaccine or for cancer therapy
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
› Verified 8 days ago
| Entity Name | Medical Laboratories Of Marquette Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285681155 PECOS PAC ID: 6800802661 Enrollment ID: O20060302000555 |
News Archive
PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.
Fear of public reporting of mortality rates may explain why cardiologists in New York are less likely than cardiologists in Michigan to perform angioplasty and other percutaneous coronary interventions on higher risk patients, according to a new study in the June 7, 2005, issue of the Journal of the American College of Cardiology.
Today the United States Centers for Disease Control and Prevention issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis. In these landmark guidelines, CDC advises that Interferon Gamma Release Assay blood tests are now preferred over the 100+-year-old tuberculin skin test for diagnosing TB infection in certain populations, including people who typically do not return for the necessary reading of TST results, and those who have received Bacille Calmette-Guerin as a vaccine or for cancer therapy
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Andrus Pahn, DO 350 W 11th St, Iu Health Pathology Lab, Indianapolis, IN 46202-4108 Ph: (317) 491-6213 | Dr Brian Andrus Pahn, DO 850 W Baraga Ave, Marquette, MI 49855-4550 Ph: (906) 449-3246 |
News Archive
PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.
Fear of public reporting of mortality rates may explain why cardiologists in New York are less likely than cardiologists in Michigan to perform angioplasty and other percutaneous coronary interventions on higher risk patients, according to a new study in the June 7, 2005, issue of the Journal of the American College of Cardiology.
Today the United States Centers for Disease Control and Prevention issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis. In these landmark guidelines, CDC advises that Interferon Gamma Release Assay blood tests are now preferred over the 100+-year-old tuberculin skin test for diagnosing TB infection in certain populations, including people who typically do not return for the necessary reading of TST results, and those who have received Bacille Calmette-Guerin as a vaccine or for cancer therapy
Genencor International, Inc. today announced that it has agreed to sell its therapeutic vaccine program to Belgian biotechnology company Innogenetics N.V. Innogenetics will develop and commercialize current product candidates in Genencor's vaccine product portfolio as well as future products based on intellectual property and technology held by Genencor.
› Verified 8 days ago
Dr. Randolph Edward Smith, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 420 W Magnetic St, Marquette, MI 49855 Phone: 906-228-9440 | |
Dr. George Alan Krzymowski, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 | |
Dr. Jeffrey Allen Conklin, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 | |
Dr. Martin Hugh Matthews, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 906-449-3000 | |
Dr. Chunming Liu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 850 W Baraga Ave, Marquette, MI 49855 Phone: 800-288-8325 | |
Dr. John David Weiss, MD Pathology Medicare: Medicare Enrolled Practice Location: 420 W Magnetic St, Marquette, MI 49855 Phone: 906-228-9440 |